Australian Prescriber

What Australian Prescriber does

Australian Prescriber is an independent, peer-reviewed medical journal published by Therapeutic Guidelines Ltd, a not-for-profit private company headquartered in North Melbourne, Victoria. The journal publishes bimonthly issues providing critical commentary on drugs and therapeutics for Australian healthcare professionals, principally general practitioners and pharmacists. Editorial output is governed by a strict policy of author independence from pharmaceutical industry financial ties, and content is published with Crossref DOIs and indexed for academic discoverability.

The publication is delivered across multiple formats including a website, downloadable PDFs, email, podcasts, and social media channels (LinkedIn, Instagram, Facebook, X). Beyond the core journal, Australian Prescriber offers accredited CPD modules for GPs (via RACGP) and pharmacists (via PSA), as well as a short-form New Drug Comments series covering newly TGA-approved agents. Subscriptions to the journal are free and distributed via the Therapeutic Guidelines subscriber base, indicating the journal functions as an embedded service of its parent rather than a standalone monetised product.

Australian Prescriber operates with a lean staff of 5 employees, supported by an Advisory Editorial Committee of practising clinicians and hospital pharmacists. The organisation has no disclosed funding rounds, patents, awards, acquisitions, or international operations, and functions as a not-for-profit editorial vehicle under its parent publisher rather than a commercial subscription business.

Name

Australian Prescriber

Legal name

Therapeutic Guidelines Ltd

Website

https://australianprescriber.tg.org.au

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Australian Prescriber is an independent, peer-reviewed medical journal published by Therapeutic Guidelines Ltd, delivering free drug and therapeutics commentary, accredited CPD modules, and podcasts to Australian GPs and pharmacists via web, email, and social channels.

Ownership category

akta.pro rank

Product category

Peer-reviewed Medical Publishing

akta.pro primary industry

Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)

Keywords

• Peer-reviewed medical journal
• Drug therapeutics commentary
• Continuing professional development
• Evidence-based prescribing
• Healthcare professional publishing

Headquarters

HQ city

North Melbourne

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2C

Offering type

Digital Commerce or Content

Cost components

Personnel, Operations, Technology or R&D, Others

Revenue model

1. Free Journal Subscriptions: Free subscriptions for Australian Prescriber are available through Therapeutic Guidelines, indicating the publication is likely funded as part of Therapeutic Guidelines Ltd's not-for-profit mission to support evidence-based prescribing in Australia.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Australian Prescriber is an independent peer-reviewed journal that provides critical commentary on drugs and therapeutics for Australian health professionals. It publishes clinical articles, new drug evaluations, and practice guides, and delivers accredited continuing professional development (CPD) content for general practitioners and pharmacists through its website, podcasts, and PDF issues. The journal is offered free of charge, with subscriptions managed through Therapeutic Guidelines Ltd.

Product overview

Australian Prescriber is a free, independent peer-reviewed journal published by Therapeutic Guidelines Ltd that provides critical commentary on drugs and therapeutics for health professionals. The publication operates as a single unified product—a peer-reviewed medical journal—delivered through multiple channels: the website (australianprescriber.tg.org.au), PDF downloads, audio podcasts, and CPD (Continuing Professional Development) modules for GPs and pharmacists. The journal features article content covering therapeutic topics, new drug reviews, letters to the editor, and accredited educational activities. Notable content modules include new drug monographs for recently approved medications such as bulevirtide (Hepcludex) for hepatitis D, capivasertib (Truqap) for breast cancer, and eflornithine (Ifinwil) for neuroblastoma.

Differentiator

Problem solved

Functional benefit

Products and services

• Australian Prescriber Journal An independent peer-reviewed journal providing critical commentary on drugs and therapeutics for Australian health professionals, featuring clinical articles, new drug evaluations, practice guides, and letters to the editor. Delivered via website, PDF issues, and digital archive.
• Australian Prescriber Podcasts Audio podcast episodes featuring discussions between clinicians about articles published in the journal, covering therapeutic topics such as cardiovascular-kidney-metabolic syndrome, emergency contraception, and irritable bowel syndrome. Available on the journal website.
• CPD for GPs Continuing Professional Development activities accredited for general practitioners, linked to journal articles and accompanied by reflective questions for self-reporting through medical colleges.
• CPD for Pharmacists Continuing Professional Development activities for pharmacists, offered through Therapeutic Guidelines, supporting professional development accreditation requirements.

Named customers2 records

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• Therapeutic Guidelines LtdcoreStrategic or Co-development PartnerTherapeutic Guidelines Ltd is the parent organization and publisher of Australian Prescriber. It is a not-for-profit organization that develops and publishes evidence-based clinical guidelines and the independent peer-reviewed journal for Australian health professionals.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Emerging players

• Medscape: Digital platform providing clinical news, drug information, and CME-accredited content free to healthcare professionals. Comparable as a free, multi-channel continuing medical education and prescribing information resource for clinicians.
• DynaMed: Evidence-based clinical decision support tool providing drug information and treatment guidance at the point of care. Comparable as an evidence-based clinical reference used by prescribing clinicians, though embedded in clinical workflows rather than journal format.

Broad incumbents

• BMJ (British Medical Journal): Major international peer-reviewed medical journal published by BMJ Group. Comparable as a peer-reviewed clinical journal serving prescribing clinicians, but at much larger scale and broader scope than Australian Prescriber.
• New England Journal of Medicine (NEJM): Premier international peer-reviewed medical journal. Comparable as a peer-reviewed journal serving prescribing clinicians, though at vastly larger scale, broader content scope, and global reach.
• The Lancet: Leading international peer-reviewed general medical journal. Comparable as a peer-reviewed journal serving prescribing clinicians globally, though operating at much larger scale and broader geographic reach.
• JAMA: International peer-reviewed medical journal published by the American Medical Association. Comparable as a peer-reviewed general medical journal, though at significantly larger scale and broader remit.

Direct peers

• NPS MedicineWise: Australian not-for-profit focused on quality use of medicines and independent drug information for health professionals and consumers. Highly comparable mission around independent, evidence-based prescribing guidance in Australia.
• Medical Journal of Australia (MJA): Australia's flagship peer-reviewed general medical journal published by the Australian Medical Association. Directly comparable as a domestic, peer-reviewed clinical journal targeting Australian healthcare professionals with CPD-relevant content.
• Australian Pharmacist: Peer-reviewed journal published by the Pharmaceutical Society of Australia, targeting Australian pharmacists with CPD content. Directly comparable in audience overlap (pharmacists) and CPD-accredited journal format.
• Prescriber (UK): Peer-reviewed journal providing independent drug and therapeutics commentary for UK prescribers. Directly comparable in editorial mission (independent prescribing commentary for clinicians) and journal format.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/AustPrescriber
• Facebookfacebook.com/AustralianPrescriber
• LinkedInlinkedin.com/company/australian-prescriber
• Instagraminstagram.com/australian_prescriber

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Australian Prescriber